147 related articles for article (PubMed ID: 17365670)
1. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenesis of murine erythroleukemia cell line transfected with exogenous p53 gene.
Sun D; Wang J; Yao W; Gu L; Wen Z; Shu C
Clin Hemorheol Microcirc; 2004; 30(2):117-26. PubMed ID: 15004336
[TBL] [Abstract][Full Text] [Related]
3. Alterations in hemorheological properties of erythrocytes in nude mice with erythroleukemia and the treatment effects of etoposide.
Xu X; Zeng Z; Yao W; Sun D; Ka W; Zhou S; Wen Z
Clin Hemorheol Microcirc; 2005; 33(4):347-61. PubMed ID: 16317244
[TBL] [Abstract][Full Text] [Related]
4. Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells.
Yao W; Gu L; Sun D; Ka W; Wen Z; Chien S
Cell Motil Cytoskeleton; 2003 Sep; 56(1):1-12. PubMed ID: 12905527
[TBL] [Abstract][Full Text] [Related]
5. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
Wang H; Lai B; Li J
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
[TBL] [Abstract][Full Text] [Related]
6. Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia.
Prasher JM; Elenitoba-Johnson KS; Kelley LL
Oncogene; 2001 May; 20(23):2946-55. PubMed ID: 11420707
[TBL] [Abstract][Full Text] [Related]
7. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
[TBL] [Abstract][Full Text] [Related]
8. [Pathological studies on the anti-invasive character of IL-6 gene transfected leukemia cells].
Ge L; Cao X; Ma D
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):409-11. PubMed ID: 8697988
[TBL] [Abstract][Full Text] [Related]
9. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias.
Howard J; Ung Y; Adachi D; Ben-David Y
Cell Growth Differ; 1996 Dec; 7(12):1651-60. PubMed ID: 8959333
[TBL] [Abstract][Full Text] [Related]
10. [FTIR spectroscopy studies on the apoptosis-promoting effect of TFAR19 on the erythroleukemia cell line MEL].
Gu L; Xie L; Yao W; Ka W; Sun D; Wen Z
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):449-52. PubMed ID: 15250154
[TBL] [Abstract][Full Text] [Related]
11. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma gene deficiency has mitogenic but not tumorigenic effects on erythropoiesis.
Hu N; Gulley ML; Kung JT; Lee EY
Cancer Res; 1997 Sep; 57(18):4123-9. PubMed ID: 9307303
[TBL] [Abstract][Full Text] [Related]
13. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.
Puca R; Nardinocchi L; Gal H; Rechavi G; Amariglio N; Domany E; Notterman DA; Scarsella M; Leonetti C; Sacchi A; Blandino G; Givol D; D'Orazi G
Cancer Res; 2008 May; 68(10):3707-14. PubMed ID: 18483253
[TBL] [Abstract][Full Text] [Related]
14. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival.
Hsiao M; Tse V; Carmel J; Tsai Y; Felgner PL; Haas M; Silverberg GD
Biochem Biophys Res Commun; 1997 Apr; 233(2):359-64. PubMed ID: 9144539
[TBL] [Abstract][Full Text] [Related]
15. Local and systemic response of mice to interferon-alpha 1-transfected Friend leukemia cells.
Gabriele L; Kaido T; Woodrow D; Moss J; Ferrantini M; Proletti E; Santodonato L; Rozera C; Maury C; Belardelli F
Am J Pathol; 1995 Aug; 147(2):445-60. PubMed ID: 7639337
[TBL] [Abstract][Full Text] [Related]
16. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene.
Cheng J; Yee JK; Yeargin J; Friedmann T; Haas M
Cancer Res; 1992 Jan; 52(1):222-6. PubMed ID: 1727382
[TBL] [Abstract][Full Text] [Related]
17. Effects of PU.1-induced mouse calcium-calmodulin-dependent kinase I-like kinase (CKLiK) on apoptosis of murine erythroleukemia cells.
Yamada T; Suzuki M; Satoh H; Kihara-Negishi F; Nakano H; Oikawa T
Exp Cell Res; 2004 Mar; 294(1):39-50. PubMed ID: 14980499
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
Liu JP; Yuan SZ; Zhang SN
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
[TBL] [Abstract][Full Text] [Related]
19. An archaeal histone-like protein mediates efficient p53 gene transfer and facilitates its anti-cancer effect in vitro and in vivo.
Li YY; Wang R; Zhang GL; Zheng YJ; Zhu P; Zhang ZM; Fang XX; Feng Y
Cancer Gene Ther; 2007 Dec; 14(12):968-75. PubMed ID: 17853924
[TBL] [Abstract][Full Text] [Related]
20. Effects of TFAR19 gene on the in vivo biorheological properties and pathogenicity of mouse erythroleukemia cell line MEL.
Gu L; Tang Z; He D; Ka W; Sun D; Wen Z
Sci China C Life Sci; 2007 Feb; 50(1):111-9. PubMed ID: 17393091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
